Neurotransmitter transporters in schistosomes: Structure, function and prospects for drug discovery

Parasitology International

Volumn 62, Issue 6, 2013, Pages 629-638

  Ribeiro, Paula ^a   Patocka, Nicholas ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Biogenic amines; Dopamine transporter (DAT); Helminth; Neurotransmitter; Neurotransmitter transporter (NTT); RNA interference (RNAi); Schistosoma; Serotonin transporter (SERT)

Indexed keywords

6 NITROQUIPAZINE; ANTIDEPRESSANT AGENT; CHLORPROMAZINE; CITALOPRAM; COCAINE; DESIPRAMINE; DOPAMINE TRANSPORTER; FLUOXETINE; IMIPRAMINE; NEUROTRANSMITTER TRANSPORTER; SEROTONIN TRANSPORTER; SODIUM IODIDE SYMPORTER; VESICULAR MONOAMINE TRANSPORTER; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; BIOGENIC AMINE; HELMINTH PROTEIN;

CLONING; DRUG TARGETING; GENE EXPRESSION; GENOMICS; HETEROLOGOUS EXPRESSION; HUMAN; IN VITRO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN STRUCTURE; PROTEIN TRANSPORT; REVIEW; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SIGNAL TRANSDUCTION; ANIMAL; CLASSIFICATION; CLUSTER ANALYSIS; DRUG DEVELOPMENT; DRUG EFFECTS; GENETICS; HOMEOSTASIS; METABOLISM; PARASITOLOGY; RNA INTERFERENCE; SCHISTOSOMIASIS MANSONI;

INVERTEBRATA; MAMMALIA; PLATYHELMINTHES; SCHISTOSOMA; SCHISTOSOMA MANSONI; VERMES;

ANIMALS; BIOGENIC AMINES; CLUSTER ANALYSIS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DRUG DISCOVERY; GENOMICS; HELMINTH PROTEINS; HOMEOSTASIS; HUMANS; NEUROTRANSMITTER AGENTS; NEUROTRANSMITTER TRANSPORT PROTEINS; RNA INTERFERENCE; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SIGNAL TRANSDUCTION;

EID: 84885386465     PISSN: 13835769     EISSN: 18730329     Source Type: Journal    
DOI: 10.1016/j.parint.2013.06.003     Document Type: Review

References (99)

1. Hotez P.J. A plan to defeat neglected tropical diseases. Sci Am 2010, 302(1):90-94.
2. Steinmann P., Keiser J., Bos R., Tanner M., Utzinger J. Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis 2006, 6(7):411-425.
3. Hotez P.J., Kamath A. Neglected tropical diseases in sub-Saharan Africa: review of their prevalence, distribution, and disease burden. PLoS Negl Trop Dis 2009, 3(8):e412.
4. King C.H., Dangerfield-Cha M. The unacknowledged impact of chronic schistosomiasis. Chronic Illn 2008, 4(1):65-79.
5. Xiao S.H., Catto B.A., Webster L.T. Effects of praziquantel on different developmental stages of Schistosoma mansoni in vitro and in vivo. J Infect Dis 1985, 151(6):1130-1137.
6. Sabah A.A., Fletcher C., Webbe G., Doenhoff M.J. Schistosoma mansoni: chemotherapy of infections of different ages. Exp Parasitol 1986, 61(3):294-303.
7. Melman S.D., Steinauer M.L., Cunningham C., Kubatko L.S., Mwangi I.N., Wynn N.B., et al. Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoni. PLoS Negl Trop Dis 2009, 3(8):e504.
8. Keiser J., Utzinger J. Advances in the discovery and development of trematocidal drugs. Expert Opin Drug Discov 2007, 2(Suppl.1):S9-S23.
9. Doenhoff M.J., Cioli D., Utzinger J. Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis. Curr Opin Infect Dis 2008, 21:659-667.
10. Hagel I., Giusti T. Ascaris lumbricoides: an overview of therapeutic targets. Infect Disord Drug Targets 2010, 10(5):349-367.
11. Ribeiro P., Geary T. Neuronal signaling in schistosomes: current status and prospects for post genomics. Can J Zool 2010, 88:1-22.
12. Holden-Dye L., Walker R.J. Anthelmintic drugs. The C. elegans research community 2007, WormBook. 10.1895/wormbook.1.143.1. WormBook (Ed.).
13. Rufener L., Keiser J., Kaminsky R., Mäser P., Nilsson D. Phylogenomics of ligand-gated ion channels predicts monepantel effect. PLoS Pathog 2010, 6(9):e1001091.
14. 2+ channels targets of praziquantel action?. Int J Pharmacol 2005, 35:1-9.
15. Jeziorski M.C., Greenberg R.M. Voltage-gated calcium channel subunits from platyhelminths: potential role in praziquantel action. Int J Parasitol 2006, 36:625-632.
16. Halton D.W., Maule A.G. Flatworm nerve-muscle: structural and functional analysis. Can J Zool 2004, 82:316-333.
17. Ribeiro P., El-Shehabi F., Patocka N. Classical transmitters and their receptors in flatworms. Parasitology 2005, 131:S19-S40.
18. Ribeiro P., Gupta V., El-Sakkary N. Biogenic amines and the control of neuromuscular signaling in schistosomes. Invert Neurosci 2012, 12(1):53-61.
19. Komuniecki R.W., Hobson R.J., Rex E.B., Hapiak V.M., Komuniecki P.R. Biogenic amine receptors in parasitic nematodes: what can be learned from Caenorhabditis elegans?. Mol Biochem Parasitol 2004, 137:1-11.
20. Zamanian M., Kimber M.J., McVeigh P., Carlson S.A., Maule A.G., Day T.A. The repertoire of G protein-coupled receptors in the human parasite Schistosoma mansoni and the model organism Schmidtea mediterranea. BMC Genomics 2011, 12:596.
21. Wolstenholme A.J. Ion channels and receptor as targets for the control of parasitic nematodes. Int J Parasitol Drugs Drug Resist 2011, 1:2-13.
22. Gether U., Andersen P.H., Larsson O.M., Schousboe A. Neurotransmitter transporters: molecular function of important drug targets. Trends Pharmacol Sci 2006, 27(7):375-383.
23. Kristensen A.S., Andersen J., Jørgensen T.N., Sørensen L., Eriksen J., Loland C.J., et al. SLC6 neurotransmitter transporters: structure, function, and regulation. Pharmacol Rev 2011, 63:585-640.
24. Sluder A., Shah S., Cassayre J., Clover R., Maienfisch P., Molleyres L.P., et al. Spiroindolines identify the vesicular acetylcholine transporter as a novel target for insecticide action. PLoS One 2012, 7(5):e34712.
25. Rudnick G., Clark J. From synapse to vesicle: the reuptake and storage of biogenic amine neurotransmitters. Biochim Biophys Acta 1993, 1144(3):249-263.
26. Eulenburg V., Gomeza J. Neurotransmitter transporters expressed in glial cells as regulators of synapse function. Brain Res Rev 2010, 63:103-112.
27. Carneiro A.M., Blakely R.D. Serotonin-, protein kinase C-, and Hic-5-associated redistribution of the platelet serotonin transporter. J Biol Chem 2006, 281:24769-24780.
28. Gordon J., Barnes N.M. Lymphocytes transport serotonin and dopamine: agony or ecstasy?. Trends Immunol 2003, 24:438-443.
29. Chaudhry F.A., Edwards R.H., Fonnum F. Vesicular neurotransmitter transporters as targets for endogenous and exogenous toxic substances. Annu Rev Pharmacol Toxicol 2008, 48:277-301.
30. Kanai Y., Hediger M.A. The glutamate/neutral amino acid transporter family SLC1: molecular, physiological and pharmacological aspects. Pflugers Arch 2004, 447:469-479.
31. Chen N.H., Reith M.E., Quick M.W. Synaptic uptake and beyond: the sodium- and chloride-dependent neurotransmitter transporter family SLC6. Pflugers Arch 2004, 447:519-531.
32. Broer S. The SLC6 orphans are forming a family of amino acid transporters. Neurochem Int 2006, 48:559-567.
33. --dependent neurotransmitter transporters. Nature 2005, 437:215-223.
34. Henry L.K., DeFelice L.J., Blakely R.D. Getting the message across: a recent transporter structure shows the way. Neuron 2006, 49:791-796.
35. Wang C.A., Lewis R.J. Emerging structure-function relationships defining monoamine NSS transporter substrate and ligand affinity. Biochem Pharmacol 2010, 79:1083-1091.
36. +-symporters with inverted repeats. Curr Opin Struct Biol 2009, 19:425-432.
37. Forrest L.R., Krämer R., Ziegler C. The structural basis of secondary active transport mechanisms. Biochim Biophys Acta 2011, 1807:167-188.
38. Singh S.K., Piscitelli C.L., Yamashita A., Gouaux E. A competitive inhibitor traps LeuT in an open-to-out conformation. Science 2008, 322:1655-1661.
39. Talvenheimo J., Fishkes H., Nelson P.J., Rudnick G. The serotonin transporter-imipramine "receptor". J Biol Chem 1983, 258:6115-6119.
40. Gu H., Wall S.C., Rudnick G. Stable expression of biogenic amine transporters reveals differences in inhibitor sensitivity, kinetics, and ion dependence. J Biol Chem 1994, 269:7124-7130.
41. --dependent transporters. Proc Natl Acad Sci 2007, 104:12761-12766.
42. Zomot E., Bendahan A., Quick M., Zhao Y., Javitch J.A., Kanner B.I. Mechanism of chloride interaction with neurotransmitter:sodium symporters. Nature 2007, 449(7163):726-730.
43. Skovstrup S., Taboureau O., Bräuner-Osborne H., Jørgensen F.S. Homology modelling of the GABA transporter and analysis of tiagabine binding. ChemMedChem 2010, 5(7):986-1000.
44. Caveney S., Cladman W., Verellen L.A., Donly C. Ancestry of neuronal monoamine transporters in the metazoa. J Exp Biol 2006, 209:4858-4868.
45. Bradley C.C., Blakely R.D. Alternative splicing of the human serotonin transporter gene. J Neurochem 1997, 69:1356-1367.
46. Patocka N., Ribeiro P. Characterization of a serotonin transporter in the parasitic flatworm, Schistosoma mansoni: cloning, expression and functional analysis. Mol Biochem Parasitol 2007, 154:125-133.
47. Fontana A.C., Sonders M.S., Pereira-Junior O.S., Knight M., Javitch J.A., Rodrigues V., et al. Two allelic isoforms of the serotonin transporter from Schistosoma mansoni display electrogenic transport and high selectivity for serotonin. Eur J Pharmacol 2009, 616:48-57.
48. Ogasawara M., Yamauchi K., Satoh Y., Yamaji R., Inui K., Jonker J.W., et al. Recent advances in molecular pharmacology of the histamine systems: organic cation transporters as a histamine transporter and histamine metabolism. J Pharmacol Sci 2006, 101:24-30.
49. Ramamoorthy S., Shippenberg T.S., Jayanthi L.D. Regulation of monoamine transporters: role of transporter phosphorylation. Pharmacol Ther 2011, 129(2):220-238.
50. Madsen K.K., White H.S., Schousboe A. Neuronal and non-neuronal GABA transporters as targets for antiepileptic drugs. Pharmacol Ther 2010, 125:394-401.
51. Berriman M., Haas B.J., LoVerde P.T., Wilson R.A., Dillon G.P., Cerqueira G.C., et al. The genome of the blood fluke Schistosoma mansoni. Nature (London) 2009, 460:352-358.
52. Protasio A.V., Tsai I.J., Babbage A., Nichol S., Hunt M., Aslett M.A., et al. A systematically improved high quality genome and transcriptome of the human blood fluke Schistosoma mansoni. PLoS Negl Trop Dis 2012, 6(1):e1455.
53. Larsen M.B., Fontana A.C., Magalhães L.G., Rodrigues V., Mortensen O.V. A catecholamine transporter from the human parasite Schistosoma mansoni with low affinity for psychostimulants. Mol Biochem Parasitol 2011, 177:35-41.
54. Verlinden H., Vleugels R., Marchal E., Badisco L., Pfluger H.J., Blenau W., et al. The role of octopamine in locusts and other arthropods. J Insect Physiol 2010, 56(SI):854-867.
55. Nishimura K., Kitamura Y., Inoue T., Umesono Y., Yoshimoto K., Taniguchi T., et al. Characterization of tyramine beta-hydroxylase in planarian Dugesia japonica: cloning and expression. Neurochem Int 2008, 53:184-192.
56. Ribeiro P., Webb R.A. The occurrence and synthesis of octopamine and other biogenic amines in the cestode Hymenolepis diminuta. Mol Biochem Parasitol 1983, 7:53-62.
57. Miller C.L., Day T.A., Bennett J.L., Pax R.A. Schistosoma mansoni - l-glutamate-induced contractions in isolated muscle fibers - evidence for a glutamate transporter. Exp Parasitol 1996, 84:410-419.
58. Mendonça-Silva D.L., Pessoa R.F., Noel F. Evidence for the presence of glutamatergic receptors in adult Schistosoma mansoni. Biochem Pharmacol 2002, 64:1337-1344.
59. Taman A., Ribeiro P. Glutamate-mediated signaling in Schistosoma mansoni: a novel glutamate receptor is expressed in neurons and the female reproductive tract. Mol Biochem Parasitol 2011, 176:42-50.
60. Taman A., Ribeiro P. Characterization of a truncated metabotropic glutamate receptor in a primitive metazoan, the parasitic flatworm Schistosoma mansoni. PLoS One 2011, 6(11):e27119.
61. Mendonça-Silva D.L., Gardino P.F., Kubrusly R.C.C., Mello F.G., Noel F. Characterization of GABAergic neurotransmission in adult Schistosoma mansoni. Parasitology 2004, 129:137-146.
62. Baard A.P., Sommers D.K., Honiball P.J., Fourie E.D., Du Toit L.E. Preliminary results in human schistosomiasis with Ro11-3128. S Afr Med J 1979, 55:617-618.
63. Noel F., Mendonca-Silva D.L., Thibaut J.-P.B., Lopes D.V.S. Characterization of two classes of benzodiazepine binding sites in Schistosoma mansoni. Parasitology 2007, 134:1003-1012.
64. Mellin T.N., Busch R.D., Wang C.C., Kath G. Neuropharmacology of the parasitic trematode, Schistosoma mansoni. Am J Trop Med Hyg 1983, 32(1):83-93.
65. Boyle J.P., Zaide J.V., Yoshino T. Schistosoma mansoni: effects of serotonin and serotonin receptor antagonists on motility and length of primary sporocysts in vitro. Exp Parasitol 2000, 94:217-226.
66. Pax R.A., Siefker C., Bennett J.L. Schistosoma mansoni: differences in acetylcholine, dopamine and serotonin control of circular and longitudinal parasite muscles. Exp Parasitol 1984, 58:312-324.
67. Day T.A., Bennett J.L., Pax R.A. Serotonin and its requirement for maintenance of contractility in muscle fibres isolated from Schistosoma mansoni. Parasitology 1994, 108:425-432.
68. Boyle J.P., Yoshino T.P. Serotonin-induced muscular activity in Schistosoma mansoni larval stages: importance of 5-HT transport and role in daughter sporocyst production. J Parasitol 2005, 91:542-550.
69. Taft A.S., Norante F.A., Yoshino T.P. The identification of inhibitors of Schistosoma mansoni miracidial transformation by incorporating a medium-throughput small-molecule screen. Exp Parasitol 2010, 125:84-94.
70. Bennett J.L., Bueding E. Uptake of 5-hydroxytryptamine by Schistosoma mansoni. Mol Pharmacol 1973, 9(3):311-319.
71. Catto B.A., Ottensen E.A. Serotonin uptake in schistosomules of Schistosoma mansoni. Comp Biochem Physiol 1979, 63C:235-242.
72. Boyle J.P., Hillyer J.F., Yoshino T.P. Pharmacological and autoradiographical of serotonin transporter-like activity in sporocysts of the human blood fluke, Schistosoma mansoni. J Comp Physiol A 2003, 189:631-641.
73. Hamdan F.F., Ribeiro P. Characterization of a stable form of tryptophan hydroxylase from the human parasite Schistosoma mansoni. J Biol Chem 1999, 274(31):21746-21754.
74. Osloobi N., Webb R.A. Localization of a sodium-dependent high-affinity serotonin transporter and recruitment of exogenous serotonin by the cestode Hymenolepis diminuta: an autoradiographic and immunohistochemical study. Can J Zool 1999, 77:1265-1277.
75. Martin R.J., Robertson A.P., Bjorn H. Target sites of anthelmintics. Parasitology 1997, 114(Suppl. S):S111-S124.
76. Patocka N., Ribeiro P. The functional role of a serotonin transporter in Schistosoma mansoni elucidated through immunolocalization and RNA interference (RNAi). Mol Biochem Parasitol 2013, 187:32-42.
77. Hamdan F.F., Abramovitz M., Mousa A., Xie J., Durocher Y., Ribeiro P. A novel Schistosoma mansoni G protein-coupled receptor is responsive to histamine. Mol Biochem Parasitol 2002, 119(1):75-86.
78. El-Shehabi F., Vermeire J., Yoshino T., Ribeiro P. Developmental expression analysis and immunolocalization of a biogenic amine receptor in Schistosoma mansoni. Exp Parasitol 2009, 122:17-27.
79. El-Shehabi F., Ribeiro P. Histamine signaling in Schistosoma mansoni: immunolocalization and characterization of a new histamine receptor (SmGPR-2). Int J Parasitol 2010, 40:1395-1406.
80. Orido Y. Histochemical evidence of the catecholamine-associated nervous system in certain schistosome cercariae. Parasitol Res 1989, 76:146-149.
81. Hamdan F., Ribeiro P. Cloning, functional expression and characterization of a novel form of tyrosine hydroxylase from the human parasite, Schistosoma mansoni. J Neurochem 1998, 71:1369-1380.
82. Taman A., Ribeiro P. Investigation of a dopamine receptor in Schistosoma mansoni: functional studies and immunolocalization. Mol Biochem Parasitol 2009, 168:24-33.
83. El-Shehabi F., Taman A., Moali L.S., El-Sakkary N., Ribeiro P. A novel G protein-coupled receptor of Schistosoma mansoni (SmGPR-3) is activated by dopamine and is widely expressed in the nervous system. PLoS Negl Trop Dis 2012, 6(2):e1523.
84. Venturini G., Stocchi F., Margotta V., Ruggieri S., Bravi D., Ballantuono P., et al. A pharmacological study of dopaminergic receptors in planaria. Neuropharmacology 1989, 28:1377-1382.
85. Buttarelli F.R., Pontieri F.E., Margotta V., Palladini G. Acetylcholine:dopamine interaction in planaria. Comp Biochem Physiol C 2000, 125:225-231.
86. Nishimura K., Kitamura Y., Inoue T., Umesono Y., Sano S., Yoshimoto K., et al. Reconstruction of dopaminergic neural network and locomotion function in planarian regenerates. Dev Neurobiol 2007, 67:1059-1078.
87. Raffa R.B., Holland L.J., Schulingkamp R.J. Quantitative assessment of dopamine D2 antagonist activity using invertebrate (Planaria) locomotion as a functional endpoint. J Pharmacol Toxicol Methods 2001, 45:223-226.
88. Rawls S.A., Cavallo F., Capasso A., Ding Z., Raffa R.B. The beta-lactam antibiotic ceftriaxone inhibits physical dependence and abstinence-induced withdrawal from cocaine, amphetamine, methamphetamine, and clorazepate in planarians. Eur J Pharmacol 2008, 584(2-3):278-284.
89. Pagan O.R., Baker D., Deats S., Montgomery E., Tenaglia M., Randolph C., et al. Planarians in pharmacology: parthenolide is a specific behavioral antagonist of cocaine in the planarian Girardia tigrina. Int J Dev Biol 2012, 56:193-196.
90. Abdulla M.-H., Ruelas D.S., Wolff B., Snedecor J., Lim K.-C., Xu F., et al. Drug discovery for schistosomiasis: hit and lead compounds identified in a library of known drugs by medium-throughput phenotypic screening. PLoS Negl Trop Dis 2009, 3(7):e478.
91. Jorgensen S., Nielsen E.O., Peters P., Dyhring T. Validation of a fluorescence-based high-throughput assay for the measurement of neurotransmitter transporter uptake activity. J Neurosci Methods 2008, 169:168-176.
92. Singh R., Pittas M., Heskia I., Xu F., McKerrow J.H., Caffrey C. Automated image-based phenotypic screening for high-throughput drug discovery. IEEE Symposium on Computer-Based Medical Systems (CBMS) 2009, 1-8.
93. Boyle J.P., Wu X.J., Shoemaker C.B., Yoshino T.P. Using RNA interference to manipulate endogenous gene expression in Schistosoma mansoni sporocysts. Mol Biochem Parasitol 2003, 128:205-215.
94. Nabhan J., El-Shehabi F., Patocka N., Ribeiro P. The 26S proteasome in Schistosoma mansoni: bioinformatics analysis, developmental expression and RNA interference (RNAi) studies. Exp Parasitol 2007, 117:337-347.
95. Krautz-Peterson G., Radwanska M., Ndegwa D., Shoemaker C.B., Skelly P.J. Optimizing gene suppression in schistosomes using RNA interference. Mol Biochem Parasitol 2007, 153:194-202.
96. Ndegwa D., Krautz-Peterson G., Skelly P.J. Protocols for gene silencing in schistosomes. Exp Parasitol 2007, 117:284-291.
97. Correnti J.M., Brindley P.J., Pearce E.J. Long-term suppression of cathepsin B levels by RNA interference retards schistosome growth. Mol Biochem Parasitol 2005, 143:209-215.
98. Tchoubrieva E.B., Ong P.C., Pike R.N., Brindley P.J., Kalinna B.H. Vector-based RNA interference of cathepsin B1 in Schistosoma mansoni. Cell Mol Life Sci 2010, 67:3739-3748.
99. Henry L.K., Field J.R., Adkins E.M., Parnas M.L., Vaughan R.A., Zou M.F., et al. Tyr-95 and Ile-172 in transmembrane segments 1 and 3 of human serotonin transporters interact to establish high affinity recognition of antidepressants. J Biol Chem 2006, 281(4):2012-2023.